Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malu Lian Hestdalen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancer Genomics & Proteomics|December 27, 2024
Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/<i>MECOM</i> Rearrangement, <i>SF3B1</i> Mutation, and Transient <i>TNIP1::PDGFRB</i> ChimeraKristin Andersen, Geir E Tjønnfjord, Malu Lian Hestdalen, et al.
The American Journal of Case Reports|March 7, 2026
Cryoglobulinemia Type II: Sustained Remission After B-Cell-Directed TherapySara Giæver Suul, Ann Kristin Kvam, Malu Lian Hestdalen, et al.
British Journal of Haematology|March 7, 2022
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccinationJon Riise, Saskia Meyer, Isaac Blaas, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancer Genomics & Proteomics|December 27, 2024
Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/<i>MECOM</i> Rearrangement, <i>SF3B1</i> Mutation, and Transient <i>TNIP1::PDGFRB</i> ChimeraKristin Andersen, Geir E Tjønnfjord, Malu Lian Hestdalen, et al.
The American Journal of Case Reports|March 7, 2026
Cryoglobulinemia Type II: Sustained Remission After B-Cell-Directed TherapySara Giæver Suul, Ann Kristin Kvam, Malu Lian Hestdalen, et al.
British Journal of Haematology|March 7, 2022
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccinationJon Riise, Saskia Meyer, Isaac Blaas, et al.
Pageof 1